Labcorp Files 8-K with Dividend-Related Exhibit

Ticker: LH · Form: 8-K · Filed: 2026-04-09T06:54:28-04:00

Sentiment: neutral

Topics: disclosure, dividend, exhibit

TL;DR

Labcorp dropped an 8-K, looks like dividend news in Exhibit 99.1.

AI Summary

On April 9, 2026, LABCORP HOLDINGS INC. filed an 8-K report detailing a Regulation FD Disclosure and Financial Statements/Exhibits. The filing includes Exhibit 99.1, which appears to be related to dividend information, as indicated by the filename 'formpr040926ex991dividenda.htm'. No specific dollar amounts or new material events were disclosed in the provided filing details.

Why It Matters

This filing indicates potential upcoming or past dividend information for Labcorp shareholders, requiring attention for investment decisions.

Risk Assessment

Risk Level: low — The filing is primarily informational, containing exhibits and disclosures without immediate material financial impact or significant strategic changes.

Key Players & Entities

FAQ

What is the specific nature of the dividend information in Exhibit 99.1?

The provided filing details do not specify the exact content of Exhibit 99.1, only that its filename suggests it relates to dividend information.

Were there any other material events disclosed in this 8-K filing besides the exhibits?

The filing lists Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits) as the relevant items, with the primary disclosed document being Exhibit 99.1.

What is the business address of LABCORP HOLDINGS INC.?

The business address is 358 S MAIN ST BURLINGTON NC 27215.

When was this 8-K filing accepted by the SEC?

The filing was accepted on 2026-04-09 at 06:54:28.

What is the CIK number for LABCORP HOLDINGS INC.?

The CIK number for LABCORP HOLDINGS INC. is 0000920148.

From the Filing

EDGAR Filing Documents for 0000920148-26-000131 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0000920148-26-000131 Filing Date 2026-04-09 Accepted 2026-04-09 06:54:28 Documents 13 Period of Report 2026-04-08 Items Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K lh-20260408.htm iXBRL 8-K 25843 2 EX-99.1 formpr040926ex991dividenda.htm EX-99.1 5677 6 GRAPHIC lc2020logov2a.gif GRAPHIC 4887 Complete submission text file 0000920148-26-000131.txt 155397 Data Files Seq Description Document Type Size 3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lh-20260408.xsd EX-101.SCH 2025 4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lh-20260408_lab.xml EX-101.LAB 22141 5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lh-20260408_pre.xml EX-101.PRE 12587 16 EXTRACTED XBRL INSTANCE DOCUMENT lh-20260408_htm.xml XML 2699 Mailing Address 358 S MAIN ST BURLINGTON NC 27215 Business Address 358 S MAIN ST BURLINGTON NC 27215 3362291127 LABCORP HOLDINGS INC. (Filer) CIK : 0000920148 (see all company filings) EIN. : 992588107 | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-11353 | Film No.: 26849776 SIC : 8071 Services-Medical Laboratories (CF Office: 08 Industrial Applications and Services)

View on Read The Filing